About the Company
Robert W. Duggan (born 1944) is an American billionaire, entrepreneur, philanthropist, biotech executive, health care executive, educator, and human rights activist. He is the former CEO of biopharmaceutical company Pharmacyclics and was previously CEO of surgical systems maker Computer Motion from 1997 to 2003. Bob is the majority shareholder and is on the boards of directors of Pulse Biosciences and Summit Therapeutics, where he is also CEO.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
100
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PLSE News
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript March 28, 2024 Pulse Biosciences, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third ...
Pulse Biosciences, Inc. (PLSE)
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript March 28, 2024 Pulse Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced business updates and ...
Pulse Biosciences Inc PLSE
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript
Greetings, and welcome to the Pulse Biosciences Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will ...
Pulse Biosciences Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Q4 2023 Pulse Biosciences Inc Earnings Call
Robert Duggan; Executive Chairman of the Board; Pulse Biosciences Inc Anthony Petrone; Analyst; Mizuho Securities Operator And greetings, and welcome to the Pulse Biosciences Fourth Quarter 2023 ...
Loading the latest forecasts...